Adenocarcinoma of the Esophagus Terminated Phase 2 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098527FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction CancerTreatment